We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aptamer Group Plc | LSE:APTA | London | Ordinary Share | GB00BNRRP542 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.70 | 0.65 | 0.75 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 1.75M | -7.84M | -0.0168 | -0.42 | 3.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/3/2024 16:14 | Worth a read. It helps explain why Optimers should be a better choice than antibodies for use in a lateral flow test for the early detection of Alzheimers Elevating Alzheimer's Detection: Aptamer Group's CSO Dr. David Bunka Discusses the Impact of Optimer Binders (published 1st March) | timbo003 | |
29/2/2024 15:07 | I think it's like a drug manufacturing license.. | icac | |
29/2/2024 14:48 | What is a Block Listing Review exactly as mentioned in today's RNS as it doesnt clearly state what's involved or why it has had such a negative impact on the share price. | paulsavannah | |
28/2/2024 21:45 | Lol certainly has letsbuy vibes.. Amaretto said trust him at 1.1p, that was the last time that price was seen loool... Watch out for this extremely desperate ramper | ddonaldson2 | |
28/2/2024 20:44 | and you are right, letsby suddenly disappeared. 🤣 | icac | |
28/2/2024 17:45 | I thought he couldn't have lowest average because he was buying from 10p, 6p and 1.2p. Amaretto you lying Sod. | icac | |
28/2/2024 17:20 | He's not the largest investor, Letsbuy1 is. Oops, they're the same person.What happened to.2p next week5p by Xmas Multiple contracts signed( that was back in December)3% RNS for your holdings.Your that far underwater you'll say anything to get gullible investors in here so you can exit breakeven. | npk2 | |
28/2/2024 16:28 | Amaretto is our largest private investor . I wish you good luck.. we are all in here too, but each investor can have their own views? correct?? no need to be aggressive ok 👌 | icac | |
28/2/2024 16:26 | hahaha 😆 amaretto, after the next raise , maybe I will have the lowest average and not you .. 🤣 how do you want your boiled egg done?? | icac | |
28/2/2024 16:06 | then why so aggressive and why so worried?? your not confident of your own investment?? | icac | |
28/2/2024 14:10 | Amaretto is just an emotional guy, he's down a lot here so let's forgive him. I've got no beef against anyone. been trading stock for a while now, just expressing my view that there will be a raise coming.. I've known Timbo also from NUOG days. and as I can remember there were also many aggressive chat members on that board insisting no raise, and share price will x amount of bag soon. what happened?? the whole board got wiped out cause it got delisted | icac | |
28/2/2024 12:20 | Thanks timbo, that makes sense.amaretto, grow up. | npk2 | |
28/2/2024 11:55 | >>> amaretto please keep this thread clean and expletive free 🙂 | timbo003 | |
28/2/2024 11:18 | my view is slightly different in the short term. yes, no money needed up front for drug delivery , but this is a few years down the line. at the mean time cash flow runs out around June/July 2024, there's not be enough deals signed in the past 6 months to allow the company to be self efficient. the positive news recently is to lift the share price up so the company can get the raise in place. the raise will be for working capital and operational cost. possibly at 0.50-0.60. let's not argue, let's wait and see. IM invested from 6p so I want this to do well also. | icac | |
28/2/2024 10:46 | AstraZeneca has extended its drug delivery collaboration with #APTA Aptamer Group. The revised deal sets AstraZeneca up to build on research into the use of aptamer molecules to target renal cellsUpdate on this work soonYes that's right #APTA already in bed with Zeneca #RNS | dannymaz89 | |
28/2/2024 10:36 | Aptamer do not intend taking anything into the clinic themselves, so they will not be raising money for that purpose in the forseeable future. If anyone thinks otherwise, please show everyone where you have either heard or read this. Currently Aptamer derive their income through a fee for service model. So clients, who are mainly diagnostic companies and pharma companies pay Aptamer to conduct an agreed program of work for which Aptamer is paid. | timbo003 | |
28/2/2024 10:27 | amaretto been ramping this since 6 pence. let me ask you, how much cash left to burn??? how many deal signed since last fund raise? 1 poxy deal at few hundred K , not enough for 2 months cash burn. I can bet you anything, a fund raise coming. | icac | |
28/2/2024 09:44 | 100% they need to raise . without doubt. trials on human 2 years away.. | icac | |
28/2/2024 09:29 | When will clinical trials start on humans?Do they have the money to fund these or will there be a cash raise to enable this? | npk2 | |
28/2/2024 09:06 | cash burn out weighing income from contract signed.. working capital shrinking every month.. a we hope Rns always follow by a raise. DYOR 👌 | icac |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions